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The use of herbal therapies for treatment and management of cardiovascular diseases
(CVDs) is increasing. Plants contain a bounty of phytochemicals that have proven to be
protective by reducing the risk of various ailments and diseases. Indeed, accumulating
literature provides the scientific evidence and hence reason d’etre for the application
of herbal therapy in relation to CVDs. Slowly, but absolutely, herbal remedies are being
entrenched into evidence-based medical practice. This is partly due to the supporting
clinical trials and epidemiological studies. The rationale for this expanding interest and
use of plant based treatments being that a significant proportion of hypertensive patients
do not respond to Modern therapeutic medication. Other elements to this equation are
the cost of medication, side-effects, accessibility, and availability of drugs. Therefore,
we believe it is pertinent to review the literature on the beneficial effects of herbs and
their isolated compounds as medication for treatment of hypertension, a prevalent
risk factor for CVDs. Our search utilized the PubMed and ScienceDirect databases,
and the criterion for inclusion was based on the following keywords and phrases:
hypertension, high blood pressure, herbal medicine, complementary and alternative
medicine (CAM), nitric oxide, vascular smooth muscle cell (VSMC) proliferation, hydrogen
sulfide, nuclear factor kappa-B, oxidative stress, and epigenetics/epigenomics. Each of
the aforementioned keywords was co-joined with herb in question, and where possible
with its constituent molecule(s). In this first of a two-part review, we provide a brief
introduction of hypertension, followed by a discussion of the molecular and cellular
mechanisms. We then present and discuss the plants that are most commonly used
in the treatment and management of hypertension.
Keywords: herbal medicine, hypertension, epigenetics, oxidative stress, inflammation, nitric oxide
INTRODUCTION
Cardiovascular disease (CVD) remains the leading cause of debility and premature death (WHO,
2013), and hence a major public health problem. Out of the major risk factors, which include
diabetes, smoking, and dyslipidemia, hypertension is by far the most prevalent trigger for CVDs,
and its comorbidity with other risk factors is even more puissant (Yang et al., 2011; WHO,
2013). Hypertension is responsible for around 16.5% of annual deaths worldwide (WHO, 2013),
and is indeed the main cause of morbidity and mortality associated with CVDs (Kizhakekuttu
and Widlansky, 2010). By 2030, the annual death toll is estimated to reach 23.5 million people
(WHO, 2013). In addition to being a major player in the onset of diseases such as atherosclerosis,
stroke, peripheral artery disease, heart failure, and coronary artery disease, hypertension can also
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lead to kidney damage, dementia, or blindness (August, 2004;
Freedman and Cohen, 2016). It is important to note that May
17th of every year has been designated World Hypertension
Day by the International Society of Hypertension (ISH), and the
theme for 2013World Health Day (7th April) was Hypertension,
and hence a focus of considerable attention.
Hypertension is defined as having a systolic blood pressure
(SBP) of ≥140mmHg and a diastolic blood pressure (DBP)
of≥90mmHg (≥140/≥90mmHg; Tabassum and Ahmad, 2011).
Every 20/10 (SBP/DBP) mmHg increase indicates a higher risk
stage of hypertension; stage 1 (140–159/90–99mmHg), stage 2
(≥160/≥100mmHg; Archer, 2000; Weber et al., 2014) with the
latter stage requiring immediate medical attention (Weber et al.,
2014). Importantly, the American Society of Hypertension and
ISH recommend that individuals with blood pressure of 120–
139/80–89mmHg be considered as pre-hypertensives (Weber
et al., 2014). For targeted therapeutic interest, it is essential to
realize that pre-hypertensive individuals are three times more
likely to succumb to hypertension at a later stage of life than
their normotensive counterparts (Archer, 2000). It is important
to note that according to the Eighth Joint National Committee, it
is recommended that for the general population, pharmacologic
treatment be started at an SBP of 150mmHg orDBP of 90mmHg.
However, for patients with Chronic Kidney Disease, treatment
shall begin when the values of SBP and DBP reach 140 or
90mmHg or higher, respectively (James et al., 2014).
Elevated blood pressure is categorized into types: primary
(essential) and secondary hypertension. Secondary hypertension,
which affects 5–10% of hypertensive individuals, is due to
identifiable causes, such as diabetes and renal damage, and thus
has a relatively higher chance of being treated. On the other
hand, essential hypertension is acquired by multiple factors such
as diet, age, lifestyle, neurohumoral activity, and interactions
(Tabassum and Ahmad, 2011). Since its etiology may be more
difficult to ascertain or establish, essential hypertension is more
difficult to manage. Interestingly, the percentage of patients with
essential hypertension (90–95%) far exceed those with secondary
hypertension (Tabassum and Ahmad, 2011).
Many drugs, ranging from diuretics (Indapamide,
Furosemide, Amiloride), sympathoplegic agents (clonidine,
reserpine), renin inhibitor (Aliskiren), angiotensin converting
enzymes (ACE) inhibitors (Enalapril, Captopril, Quinapril),
angiotensin receptors blockers (ARBs—Losartan, Irbesartan,
Olmesartan), calcium channel blockers (Nifedipine, Verapamil,
Diltiazem), α-adrenergic blockers (Prazosin, Doxazosin),
β-adrenergic blockers (Nebivolol, Atenolol) to vasodilators
(Minoxidil, sodium nitroprusside), are used to manage blood
pressure levels in hypertensive patients (Archer, 2000; Susalit
et al., 2011). However, a point of interest to physicians and
health-care practitioners is the alarming, and rather unfortunate,
reality that high blood pressure is managed in only 34% of
hypertensive patients (August, 2004; Wang and Xiong, 2012).
The major concerns that often delay treatment allude to
higher costs of antihypertensive drugs (Susalit et al., 2011),
their availability and accessibility (Wang and Xiong, 2012),
the undesired side effects of antihypertensive drugs (Susalit
et al., 2011; Wang and Xiong, 2012) and the reduced patient
compliance to consume more than a pill per day (August, 2004).
Taking this into account, hypertensive patients, especially those
dwelling in rural areas, seek alternative approaches such as
herbal remedies for their treatment of hypertension and other
diseases.
HERBAL REMEDIES
The use of herbal medicine as a treatment modality has
significantly increased over the last decade (Frishman et al.,
2009). This is due to several factors, principal of which is that
herbal medicine is a cheaper alternative with fewer undesired
side effects (Frishman et al., 2009; Susalit et al., 2011; Tabassum
and Ahmad, 2011). However, the increased desire to use
herbal treatment is not a reflection of the economic status
of an individual from a certain region or a country. Indeed,
70% of the population in developed nations have resorted to
Complementary and Alternative Medicine (CAM) for treatment
purposes, and herbal medicine forms a large proportion of
its application (WHO, 2008). Further, the usage of CAM
in developing countries is becoming even more pronounced
(WHO, 2008). Evidently, the rationale for the use of herbal and
plant remedies is definitely not surprising, considering the fact
that they contain thousands of bioactive components that have
known therapeutic applications (Pan et al., 2013). Indeed, plants
and herbs have actually provided a starting point for synthesis
of over 50% of currently used pharmaceutical drugs (Pan et al.,
2013). The pharmacopeia includes ephedrine (from Ephedra
sinica), aspirin (from Salix alba), lovastatin (from Monascus
purpureus), reserpine (from Rauwolfia serpentina), and taxol
(from Taxus brevifolia; Frishman et al., 2009). Remarkably,
reserpine (which depletes adrenergic neurotransmitters) still
remains an effective treatment for hypertension (Weber et al.,
2014).
Importance of plants and herbs, per se, in the medical field
must not be overlooked as they have been used throughout
human history. Herbal plant-based formulations or drugs are
pivotal to Traditional practices in Chinese, Ayurvedic, and Unani
Tibb medicine, which is practiced worldwide. Overall, this may
explain the increasing interest in panning out the beneficial
health effects of various plants and herbs in different diseases
including hypertension (Tabassum and Ahmad, 2011). In this
review, we focus to provide a summary of different plants that
have been reported to exhibit antihypertensive properties, and
that can specifically mitigate anti-inflammatory causes in arterial
hypertension. Moreover, where information is available, we have
discussed botanical-induced improvements in renal biology.
MOLECULAR PATHOGENESIS OF
HYPERTENSION
Hypertension is characterized by arterial derangement in
the vascular tree, affecting large conduit arteries (such as
aorta), small resistance size arteries (150–400µm), and the
microcirculation (arterioles and capillaries). Increased arterial
reactivity (sensitivity and potency) due to dysregulation in
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endothelial nitric oxide synthase (eNOS) and pro-oxidant
enzymes, enhanced basal and activated calcium levels due
to overactive transmembrane calcium permeability through
calcium channels, and/or coexistence of vascular smooth muscle
cell (VSMC) hyperplasia and hypertrophy (vascular remodeling)
can all lead to increased vasoconstriction. These pathological
events lead to an increased ratio of vessel wall thickness as
compared to the dimensions of the arterial lumen (Folkow, 1990).
It is this increased ratio that plays a major role in precipitating
hypertension. Below we discuss some of the major mechanisms
implicated in the pathogenesis of hypertension. Then we discuss
the most commonly used herbs that ameliorate blood pressure by
modulating these mechanisms.
Vascular Smooth Muscle Cell (VSMC)
Proliferation
VSMCs participate in the pathogenesis of hypertension (Oparil
et al., 2003; Lacolley et al., 2012), and their proliferation
contributes to increased peripheral resistance by decreasing
arterial diameters (Oparil et al., 2003; Figure 1). For an
understanding of these intricate alterations, it is essential to
examine the modulating factors that stimulate or inhibit VSMC
growth for the treatment of hypertension. Growth factors
impel the cell into entering cell cycle until the G1 phase, the
first check point (Marx et al., 2011). These growth factors
include: platelet-derived growth factor (PDGF; Itoh et al., 1993;
Rudijanto, 2007; Marx et al., 2011), fibroblast growth factor
(FGF; Itoh et al., 1993; Rudijanto, 2007; Marx et al., 2011)
endothelin-1, thrombin, interleukin-1 (IL-1; Rudijanto, 2007),
and visfatin (Miao and Li, 2012). Angiotensin II (Ang II)
can also promote cell cycle progression especially that it can
regulate the expression of both basic FGF (Itoh et al., 1993) and
epidermal growth factor receptor (EGFR; Inagami and Eguchi,
2000).
Amongst the several VSMC growth inhibitors are nitric
oxide (NO), cyclic guanosine monophosphate (cGMP; Pilz and
Casteel, 2003), transforming growth factor-beta (TGFβ; Itoh
et al., 1993; Rudijanto, 2007), and adenosine monophosphate-
activated protein kinase (AMPK; Song and Zou, 2012).
For example, 5-aminoimidazole-4-carboxamide ribonucleotide
(AICAR), a membrane-permeable activator of AMPK, inhibits
cell cycle progression, and migration of VSMCs as well as
vascular remodeling following injury (Stone et al., 2013).
Moreover, rosiglitazone, a peroxisome proliferator-activated
receptor gamma (PPARγ) agonist, acts via protein kinase G
(PKG) to exert an anti-proliferative effect on VSMCs in models
of angioplasty-induced vascular injury (Yang et al., 2013).
Contextually, complex regulatory interactions exist between
growth factors and the VSMC phenotype (Itoh et al., 1993).
The balance between the pro-proliferative and anti-proliferative
signals determines, to a large extent, the phenotype of VSMCs.
As will be discussed later in this review, many plants and
herbs indeed ameliorate increased blood pressure by favorably
modulating the VSMC phenotype.
Endothelial Cells
The endothelial cell layer is no longer considered as an
inert entity. It rather plays significant roles in many aspects
of homeostasis along the cardiovascular network. Endothelial
function is regulated and maintained by a variety of cell surface
receptors, some of which induce the release of vasoactive
substances to regulate vascular tone and smooth muscle cell
FIGURE 1 | A schematic diagram indicating the favorable effects of plants/herbs on the molecular pathogenesis of hypertension. Different molecular,
biochemical, and cellular pathways are favorably modulated by herbs/plants or their extracts.
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proliferation (Drexler and Hornig, 1999). Local and circulating
cues stimulate the vascular endothelium to release vasodilators
(NO, prostacyclin, and endothelial-derived hyperpolarizing
factor) and vasoconstrictors (endothelin, thromboxane, and
PDGF; Iglarz and Clozel, 2007). When there is an imbalance
between these vasoactive agents, an increased production of
reactive oxygen species (ROS) may result, which then leads to
endothelial dysfunction and eventually hypertension (Virdis and
Taddei, 2011; Montezano and Touyz, 2012; Silva et al., 2012;
Figure 1).
Endothelial dysfunction anticipates the progression of
anatomically overt vascular disease, which robustly correlates
with hypertension. However, endothelial derangement could be
reversed by modification therapy, such as with herbal remedies.
This fact will be highlighted in different sections of this review.
Repertoire of Signaling Molecules
Assuming a homeostatic imbalance, the following signaling
molecular entities become integral to the pathogenesis of
hypertension (Ong andWhitworth, 2011;Montezano and Touyz,
2012). Fortunately, a diverse range of plant and herbal extracts
and their individual metabolites can modulate signaling cascades
implicated in the physiology of the cardiovascular system (see
Section Herbs and Spices Most Commonly Used for Treatment
of Hypertension, below). These herbs are not only vasculo-
protective but they could also potentially reverse the changes
in hypertension. This particularly applies if the alterations
in hypertensive patients are addressed prior to reaching a
decompensated state.
Reactive Oxygen Species
In good health, the activity of pro-oxidants is balanced by anti-
oxidative agents. However, when this equilibrium is disturbed,
the un-orchestrated milieu leads to pathologic states, such as
hypertension, atherosclerosis, and other vascular complications
(Figure 1; Montezano and Touyz, 2014). ROS such as superoxide
anions (O•−2 ) and hydroxyl ions (OH
−) play a major role
by promoting an environment of oxidative stress, which is
a primary cause in the pathogenesis of hypertension (Zeng
et al., 2009; Song and Zou, 2012; Montezano et al., 2015).
ROS are produced from the reactivity of nicotinamide-adenine
dinucleotide phosphate (NADPH) oxidase and many other
enzymatic reactions particularly ones related to the electron
transport chain within the mitochondria (Zeng et al., 2009;
Dharmashankar and Widlansky, 2010; Drummond et al., 2011;
Song and Zou, 2012). The oxidant molecules are inactivated
by antioxidant enzymes such as superoxide dismutase (SOD),
catalase (CAT), glutathione peroxidase (GPX), and non-
enzymatic substances like reduced glutathione (GSH; Song and
Zou, 2012). Recent evidence suggests that AMPK can also
suppress the activity of NADPH oxidase (Song and Zou, 2012).
An increase in the amount of ROS, and the corresponding
fall in intracellular endothelial antioxidant levels (Zeng et al.,
2009; Drummond et al., 2011; Song and Zou, 2012), signals an
oxidative stress state. The oxidative stress leads to endothelial
cell dysfunction and vascular smooth muscle remodeling by
reducing NO bioavailability (Zeng et al., 2009; Drummond
et al., 2011). ROS are also responsible for the oxidation of
low-density lipoprotein (LDL), which results in inflammation
and increased proliferation of VSMCs (Slevin et al., 2012).
Both inflammation and enhanced proliferation significantly
trigger plaque formation (Slevin et al., 2012) which in turn
may contribute to increased blood pressure. Interestingly,
blocking ROS production by exposure to antioxidants has
been shown to reduce blood pressure in rodents (Zeng et al.,
2009).
A key molecule that regulates oxidative stress in VSMCs is the
transcription factor erythroid 2-related factor 2 (Nrf2, or nuclear
factor erythroid 2-like 2). Under physiological conditions, Nrf2
activity is inhibited by its endogenous inhibitor Kelch-like ECH-
associated inhibitor 1 (Keap1; Villeneuve et al., 2013). On
the other hand, when oxidative stress ensues, Keap1 releases
Nrf2, which then translocates to the nucleus and promotes
expression of different antioxidant enzymes such as CAT, GPX,
heme oxygenase-1 (HO-1), SOD (Kern et al., 2007). Pertinently,
various phytochemicals suppress oxidative stress by upregulating
antioxidant enzymes through the Keap1–Nrf2 pathway (Tao
et al., 2013; Niture et al., 2014).
Nitric Oxide
Nitric oxide (NO) is often recognized as an important indicator
of vascular health. It plays an important role in blood pressure
regulation due to its vasodilating potency (Francis et al., 2010)
as well as its ability to inhibit aggregation of platelets and
proliferation of VSMCs (Zeng et al., 2009). NO is produced
from L-arginine (Francis et al., 2010) by NO synthases (NOS)
such as endothelial NOS (eNOS; Francis et al., 2010). After
its release, NO translocates into VSMCs and activates soluble
guanylate cyclase (sGC), which then catalyzes the conversion
and cyclization of guanosine triphosphate (GTP) to cGMP
(Francis et al., 2010). cGMP then binds to cGMP-dependent
protein kinases (PKGs; Francis et al., 2010) which modulate
calcium levels and the consequent contraction of VSMCs (Francis
et al., 2010). Within seconds of its production, NO reacts
with superoxide anions (Drummond et al., 2011) to produce
peroxynitrite (ONOO−; Drummond et al., 2011). This in itself
is a selective oxidant and can precipitate oxidative stress as
well as diminish the vasodilatory effect of NO (Drummond
et al., 2011). As such, the concentration of ROS has a direct
impact on the bioavailability of NO. Interestingly, oxidative
stress can also induce eNOS uncoupling, so that eNOS generates
free radicals instead of NO. For example, stimulation of
NADPH oxidase leads to the generation of superoxide anion
(O•−2 ), which reacts with NO to form the potent oxidizing
agent, peroxynitrite. This peroxynitrite then oxidatively degrades
the eNOS cofactor tetrahydrobiopterin (BH4) to the inactive
dihydrobiopterin (BH2). Effectively, this yields more superoxide
anion that eventually depletes BH4. Therefore, a shift in balance
from NO to superoxide formation ensues; this is referred
to as uncoupling of NOS (Michel and Vanhoutte, 2010). As
such, the interplay between NO and the regulatory mechanisms
governing its bioavailability are thus intimately intertwined
with vascular tone and endothelial dysfunction (Montezano and
Touyz, 2012).
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Hydrogen Sulfide
Hydrogen sulfide (H2S) is an important biological mediator
produced in VSMCs and potentially endothelial cells via the
catalysis of L-cysteine by the enzyme cystathionine γ-lyase (CSE;
Calvert et al., 2010; Pan et al., 2012). It has been reported
that deficiency in H2S production is positively correlated with
pathophysiology of hypertension in several animal models
(Benavides et al., 2007; Liu et al., 2012). Indeed, CSE activity
and H2S levels were notably decreased in the aorta and
plasma of SHR, respectively (Yan et al., 2004). In addition,
there was a significant increase in BP levels of Wistar Kyoto
(WKY) rats treated with DL-propargylglycine (PPG), a CSE
inhibitor (Yan et al., 2004). Furthermore, administration of H2S
is sufficient to abolish the Nω-nitro-L-arginine methyl ester
hydrochloride (L-NAME, an inhibitor of nitric oxide synthase)-
induced hypertension in WKY rats (Zhong et al., 2003).
At the molecular and cellular levels, H2S exhibits a
vasorelaxant effect on VSMCs by increasing intracellular levels
of cGMP (Bucci et al., 2012) and opening ATP-dependent
potassium channels (KATP; Banerjee et al., 2002; Calvert et al.,
2010; Bucci et al., 2012; Pan et al., 2012). Interestingly, H2S has
also been reported to prevent vascular inflammation (Calvert
et al., 2010; Pan et al., 2012), reduce ROS production, depress Ang
II and ACE levels, potentiate antioxidant mechanisms, diminish
VSMC proliferation, and induce NO synthesis (Benavides et al.,
2007).
Angiotensin II
The Renin–Angiotensin–Aldosterone (RAA) system plays a
pivotal role in regulating blood pressure (Nguyen Dinh Cat and
Touyz, 2011). Activation of the RAA system in response to a
decrease in cardiac output leads to the secretion of renin, which in
turn catalyzes the conversion of angiotensinogen to angiotensin I
(Ang I). Ang I is then cleaved by Angiotensin Converting Enzyme
(ACE)-1 (ACE-1) to form Angiotensin II (Ang II). Ang II-
mediated hypertension occurs by promotion of sodium andwater
retention as well as enhancement of vasoconstriction by binding
to the angiotensin type 1 (AT1) receptor (Morgan, 2003; Nguyen
Dinh Cat and Touyz, 2011; Savoia et al., 2011). Activation of
AT1 receptors is known to trigger the proliferation of VSMCs
(Castro et al., 2010; discussed earlier). The fact that ACE is
present in several tissues, including arteries, indicates that Ang
II can be formed locally within the arteries themselves. Indeed,
there is a higher concentration of Ang II in the vasculature of
hypertensive compared to normotensive rats (Ma et al., 2010).
Taken together, these observations may explain why inhibiting
ACE is an attractive approach for antihypertensive therapies
(Morgan, 2003; Bernstein et al., 2013). Ang II induces aldosterone
production (Oparil et al., 2003; Manrique et al., 2009; Ma et al.,
2010) and cardiac muscle cell growth (Manrique et al., 2009; Ma
et al., 2010; Song and Zou, 2012). Blockade of AT1 receptors
improves endothelial dysfunction (Virdis et al., 2011) and has
been reported to decrease BP (Kang et al., 2009). Accumulating
evidence demonstrates that Ang II also stimulates NADPH
oxidase to generate ROS (Ma et al., 2010; Virdis et al., 2011). In
addition, Ang II may increase the sympathetic nervous system
(SNS) activity (Manrique et al., 2009), which participates in
pathogenesis of hypertension by elevating cardiac output and
increasing peripheral vascular resistance (Oparil et al., 2003).
Nuclear Factor Kappa B
Inflammation is well-documented to contribute to vascular
remodeling and consequent hypertension (Vazquez-Prieto et al.,
2011). Nuclear Factor kappa B (NF-κB), a transcription factor, is
known to partake in the pathology of hypertension. It induces
endothelial cell dysfunction, oxidative stress, and inflammation
(Li and Zhuo, 2008; Kang et al., 2009) through the release of
pro-inflammatory cytokines, such as tumor necrosis factor-alpha
(TNF-α) and interleukin-6 (IL-6; Kang et al., 2009).
It has been shown that increased expression and activation
of NF-κB contributes to renal injury and hypertension (Elks
et al., 2009). Indeed, suppressing NF-κB with pyrrolidine
dithiocarbamate (PDTC) decreased SBP in spontaneous
hypertensive rats (SHRs; Elks et al., 2009). Interestingly, PDTC
also suppressed the higher concentration of cytosolic and
mitochondrial ROS in kidneys of these SHRs (Elks et al., 2009).
Activation of NF-κB could be induced by several factors such
as Ang II (Kang et al., 2009), ROS (Kang et al., 2009), and/or
tumor necrosis factor-alpha (TNF-α; Mathew and Biju, 2008;
Zhang et al., 2009; Vazquez-Prieto et al., 2011). Interestingly,
TNF-α-induced ROS production, which drastically impacts
endothelial dysfunction, is shown to be mediated by NF-κB
(Zhang et al., 2009). Moreover, NF-κB plays an important role
in attenuation of ANG II-induced pressor response (Kang et al.,
2009), regulation of AT1 receptors (Bhatt et al., 2014; Luo et al.,
2015), as well as induction of oxidative stress (Mathew and Biju,
2008; Zhang et al., 2009; Vazquez-Prieto et al., 2011). Further, NF-
κB can increase proliferation, decrease apoptosis of endothelial
cells, as well as stimulate expression of vascular cell adhesion
molecule-1 (VCAM-1; Vazquez-Prieto et al., 2011; Jiang et al.,
2013b). Taken together, these NF-κB-induced changes can lead
to the derangement of endothelial function and vascular tone.
HERBS AND SPICES MOST COMMONLY
USED FOR TREATMENT OF
HYPERTENSION
Secondary metabolites of herbs and spices exhibit anti-
hypertensive effects. Here, we present a comprehensive
alphabetical list of herbs for which sound evidence suggests
they could be beneficial in hypertension therapy (Tables 1–6;
Figure 1).
Allium sativum (Garlic)
Garlic’s multi-fold therapeutic effects have been recognized
for thousands of years amongst different cultures around the
world, and continues to attract interest from pharmacologists
and health practitioners (Frishman et al., 2009; Qidwai and
Ashfaq, 2013; Table 2). This herb is not only known for
its hypotensive capacity, but is also characterized by anti-
inflammatory, antioxidant, antibacterial, hypocholesteremic, and
anti-cancer properties (Banerjee et al., 2002; Mousa and Mousa,
2007; Frishman et al., 2009; Qidwai and Ashfaq, 2013). For
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TABLE 1 | Commonly used antihypertensive plants with antioxidant activity.
Herb Effect Concentration/Dose Experimental setting/Model References
Allium sativum Scavenges ROS 3mg/ml Human neutrophils Morihara et al., 2011
Increases antioxidants 500mg/ml 2K-1C rats Drobiova et al., 2011
125–2000mg/kg Wistar albino rats’ hearts Banerjee et al., 2002
Reduces NADPH activity 150 and 400mg/kg Fructose-fed rats Vazquez-Prieto et al., 2011
Andrographis
paniculata
Scavenges ROS 0.7–2.8 g/kg SHR Zhang and Tan, 1996
Apium graveolens Increases antioxidants 1ml/kg (of different extracts) CCl4-treated mice Popovic et al., 2006
Camellia sinensis Scavenges ROS 1–5µg/ml Superoxide-generating system Nakagawa and Yokozawa, 2002
Decreases NADPH oxidase 13.3 g/L STZ fed SHR Ribaldo et al., 2009
Increases antioxidants 0.1% Streptozotocin (STZ)-fed Sprague-Dawley rats Thomson et al., 2012
1% Green Tea Extract C57BL/6 mice Newsome et al., 2014
Inhibits eNOS uncoupling 5 g/kg STZ fed SHR Faria et al., 2012
Coptis chinensis Increases antioxidants 150mg/kg Atherosclerotic renovascular disease (ARD)
Wistar rats
Wan et al., 2013
Decreases NADPH oxidase 150mg/kg ARD Wistar rats Wan et al., 2013
Coriandrum
sativum
Inactivates ROS produced
by β-adrenoceptor
stimulation
200 and 300mg/kg Isoproterenol-induced cardiotoxicity in male
Wistar rats.
Patel et al., 2012
Increases antioxidants 200mg/kg CCl4-induced hepatotoxicity in Wistar albino
rats
Sreelatha et al., 2009
Crataegus spp. Scavenges ROS 100–400µg/ml enzymatic assay Cheng et al., 2013
Crocus sativus Reduces oxidative stress 200mg/kg BeCl2-treated Wistar rats El-Beshbishy et al., 2012
Increases antioxidants 200mg/kg BeCl2-treated Wistar rats El-Beshbishy et al., 2012
20–80mg/kg Genotoxins-treated Swiss albino mice Premkumar et al., 2003
Hibiscus sabdariffa Scavenges ROS 2mg/ml CCl4-induced hepatotoxicity in rat liver Ajiboye et al., 2011
Increases antioxidants 10 g extract (powder),
dissolved in 200mL water
Healthy humans Frank et al., 2012
Panax Increases antioxidants 60–120µM Hypoxia/Reoxygenation-induced oxidative
injury in rat cardiomyocytes
Doh et al., 2013
Salviae miltiorrhizae Reduces ROS 100µg/ml Sprague-Dawley rat thoracic aortic VSMCs Cho et al., 2013
Increases antioxidants 5 g extract/time, twice per
day; 60 days
Chronic heart disease (CHD) patients Qian et al., 2012
Zingiber officinale Scavenges ROS 0–60µM Enzymatic assay Shin et al., 2005
Inhibits lipid peroxidation 0.05mg/ml Rat heart Akinyemi et al., 2013
health benefits, garlic can be consumed in different forms,
such as raw, aged, an aqueous extract, oil, and in powder
form (Banerjee et al., 2002; Frishman et al., 2009; Ried et al.,
2013).
Several mechanisms have been alluded to in the explanation
of garlic’s hypotensive effects (Shouk et al., 2014). These are
based on garlic’s organo-sulfur constituents such as Allicin, S-
allylcysteine (SAC), diallyl disulfides (DADS), diallyl trisulfides
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TABLE 2 | Commonly used antihypertensive plants with vasorelaxant activity.
Herb Effect Concentration/Dose Experimental setting/Model References
Allium sativum Increases NO Reported only as garlic extract Human umbilical vein endothelial cells Mousa and Mousa, 2007
0.8mg/ml Rat isolated pulmonary arteries Ku et al., 2002
Increases eNOS 150 and 400mg/kg/day Fructose-fed Wistar rats Vazquez-Prieto et al., 2011
Increases H2S 500µg/ml Sprague-Dawley rat aortic rings Benavides et al., 2007
Inhibits ACE Fructose-fed rats Sendl et al., 1992
Andrographis paniculata Increases NO 1mg/ml Isolated hearts from Sprague-Dawley rats Awang et al., 2012
Blocks Ca2+ channels 1mg/ml Isolated hearts from Sprague-Dawley rats Awang et al., 2012
Reduces ACE 0.7–2.8 g/kg SHR Zhang and Tan, 1996
Apium graveolens Blocks Ca2+ influx 48mM Rat isolated aortic rings Ko et al., 1991
Bidens pilosa L. Ca2+ antagonists 0.32mg/ml KCl-treated rat aorta Nguelefack et al., 2005
Mechanism not determined 40mg/ml High-fructose fed Wistar rats Dimo et al., 2002
Camellia sinensis Increases flow-mediated
dilation (FMD)
2 g in 250ml boiled water/day Brachial arteries of subjects with elevated
cholesterol level
Hodgson et al., 2002
450 and 900mL Brachial arteries of coronary heart disease
patients
Duffy et al., 2001
Increases NO 580mg Healthy male smokers (preclinical pilot) Oyama et al., 2010
Inhibits eNOS uncoupling 5 g/kg daily Diabetic SHR Faria et al., 2012
Blocks AT1 receptor 0.1% STZ-fed Sprague-Dawley rats Thomson et al., 2012
Coptis chinensis Upregulates eNOS
expression
2.99, 3.45, 5.81, and 6.14 g/L Rat isolated cardiomyocytes (insulin-induced
hypertrophy)
Zhang et al., 2011
2.99, 3.45, 5.81, and 6.14 g/L Isolated thoracic aorta rings from CIHH rats Zhang et al., 2011
Decreases EMP 1.2 g/L Healthy humans Affuso et al., 2010
Blocks Ca2+ channels 5.18 and 6.14 g/L Isolated thoracic aorta rings from CIHH rats Zhang et al., 2011
Crataegus spp. Activates eNOS 100mg/kg/day L-NAME-induced hypertensive rats Koçyildiz et al., 2006
100µg Male Wistar Rat isolated aortic rings Brixius et al., 2006
100µg Human isolated mammarian arterial rings Brixius et al., 2006
Crocus sativus Activates eNOS 0.1–0.5ml/kg ischemia-reperfusion (IR) in rats Bharti et al., 2012
Blocks Ca2+ channels 1 and 5 mg% Guinea pig Isolated heart Boskabady et al., 2008
Cymbopogon citratus Increases NO bioavailability 30mg/ml Isolated aorta from SHR Devi et al., 2012
30mg/ml Isolated aorta from WKR Devi et al., 2012
1–20mg/kg Rat isolated thoracic aorta Bastos et al., 2010
Inhibits Ca2+-influx 1–20mg/kg Rat isolated thoracic aorta Bastos et al., 2010
Hibiscus sabdariffa Increases NO 0.3mg/ml SHR isolated aorta Ajay et al., 2007
1500–2500mg/kg Not clear Alarcon-Alonso et al., 2012
Blocks Ca2+ channels 10 ng−1 mg/ml SHR isolated aorta Ajay et al., 2007
(Continued)
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TABLE 2 | Continued
Herb Effect Concentration/Dose Experimental setting/Model References
Opens KATP channels 10
−4–10−1 g/L Male Wistar rat thoracic aorta Sarr et al., 2009
Reduces ACE 250mg Stage 1 and 2 hypertensive humans Herrera-Arellano et al., 2007
Nigella sativa Blocks Ca2+ channels 2–14mg/ml Rat isolated aorta Niazmand et al., 2014
Panax Increases eNOS 150µg/ml SHR adrenal medulla Jang et al., 2011
Salviae miltiorrhizae Increases NO 0–10mg/ml (of SalB, a major
ingredient of this plant)
Rabbit thoracic aortic rings Shou et al., 2012
Opens KATP channels 0.25–2mg/ml SHR aorta Ng et al., 2011
Blocks Ca2+ channels 300–1000µg/ml Porcine coronary rings Hu et al., 2012
10.39 ± 1.69µM Rat coronary arterial rings Lam et al., 2008
Reduces ACE activity 0.05mg/ml Rat heart Akinyemi et al., 2013
(DATS), and methyl thiosulfonate (Banerjee et al., 2002; Qidwai
and Ashfaq, 2013).
Many hypertensive patients use garlic to lower their blood
pressure (Qidwai and Ashfaq, 2013). The reported effects vary
from significant reduction in mean arterial pressure, drop in
either SBP or DBP only, to no alteration in blood pressure at
all (Banerjee et al., 2002; Mousa and Mousa, 2007; Frishman
et al., 2009; Yang et al., 2011; Augusti et al., 2012). However, most
studies confirm the induction of hypotensive effects by garlic
and its constituents. Banerjee and Maulik reviewed pertinent
literature and concluded that different forms of garlic can reduce
SBP, DBP, or both (Banerjee et al., 2002). Also, an investigation
by Qidwai and Ashfaq indicated that an almost 80% efficacy
in anti-hypertensive effects of garlic was reported (Qidwai and
Ashfaq, 2013). Interestingly, evidence frommeta-analysis studies
indicates that aged garlic extract (AGE) produces consistent
lowering of blood pressure compared to other forms of garlic. A
recent meta-analysis of randomized, controlled trials concluded
that garlic supplements induce a significant reduction in both
SBP and DBP by 3.75 and 3.39mmHg, respectively (Wang
et al., 2015). Similarly, another meta-analysis on randomized,
controlled trials also reported a significant decrease in SBP
by 4.6 ± 2.8mmHg compared to placebo (Ried et al., 2008).
Moreover, in a double-blind, parallel randomized placebo-
controlled study, individuals with uncontrolled hypertension
(≥140mmHg) who were treated with 960mg/day of AGEs for 12
weeks exhibited an average decrease of 10.2 ± 4.3mmHg in SBP
(Ried et al., 2010). This effect appears to be due to the principle
constituent S-allylcysteine, which is relatively more stable in
relation to allicin (Ried et al., 2010). Furthermore, in another
randomized, parallel, placebo-controlled trial, patients with stage
1 hypertension ingested garlic tablets (300–1500 mg/day) for 24
weeks (Ashraf et al., 2013). This study reported a significant
decrease in SBP and DBP by a maximum of 9.2 and 6.27mmHg,
respectively (Ashraf et al., 2013).
Analysis of assays on antioxidant ability of different forms of
garlic demonstrate far greater potency in aged extracts than other
types of garlic clove derivatives (Mathew and Biju, 2008). Indeed,
AGE potently scavenges ROS (Drobiova et al., 2011; Morihara
et al., 2011) leading to an increase in cellular antioxidants
(Banerjee et al., 2002; Drobiova et al., 2011). In comparable
studies, Drobiova et al. (2011) treated two-kidney, one-clip (2K-
1C) hypertensive rats for 3 weeks with an aqueous extract of
garlic (500mg/ml), which raised the antioxidant levels by over
60% and resulted in reduction of SBP by 50%. The superoxide
scavenging abilities of AGE have also been demonstrated in
human neutrophils (Morihara et al., 2011). In addition, a daily
150 or 400mg/kg dose of garlic extracts has also been reported
to decrease NADPH oxidase in fructose-fed rats’ aorta (Vazquez-
Prieto et al., 2011).
The endogenous signaling gases, NO and H2S, are recognized
as mediators of garlic’s antihypertensive properties (Banerjee
et al., 2002; Mousa and Mousa, 2007; Ried et al., 2013). In
a clinical trial performed by Mousa and Mousa (2007) on
stage 1 hypertensive subjects (≥140mmHg), who consumed
a daily dose of 2600mg of garlic (one tablet comprising of
650mg of garlic bulb—Allium sativum—powder) for a period
of 10 days, the authors reported a significant reduction of
17mmHg in SBP, but the DBP remained unchanged (Mousa
and Mousa, 2007; Table 6). In mechanistic support of the blood
pressuremeasurements, the group exposed human umbilical vein
endothelial cells (HUVECs) to a garlic extract, which caused
an increase in the bioavailability of NO, a potent vasodilator,
by 200% (Mousa and Mousa, 2007). This is thought to occur
through the reaction between NO and the sulfide components of
garlic (Ku et al., 2002). An ethanolic extract of garlic (0.8mg/ml)
caused relaxation in rat pulmonary arteries pre-contracted with
phenylephrine (Ku et al., 2002). Another study has demonstrated
that extracts (150 and 400mg/kg daily) of garlic not only
upregulate eNOS, but also induce an increase in eNOS activity
in fructose-fed rats (Vazquez-Prieto et al., 2011). In addition,
garlic does not merely increase H2S production, but induces
its synthesis for vasorelaxant activity (Benavides et al., 2007).
In their study, Benavides et al. (2007) demonstrated that red
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TABLE 3 | Commonly used antihypertensive plants with anti-inflammatory activity.
Herb Effect Concentration/Dose Experimental setting/Model References
Allium sativum Inhibits NF-κB 250mg/kg High fructose-fed rats Padiya et al., 2014
Reduces VCAM-1 150mg/kg Fructose-fed Wistar rats Vazquez-Prieto et al., 2011
Andrographis paniculata Inhibits NF-κB 4mg/kg Npr1 gene-knockout mice Das et al., 2012
Bidens pilosa L. Inhibits NF-κB and
TNF-alpha activation
10–20µg/ml LPS-stimulated RAW 264.7 Xagorari et al., 2001
1µM Chiang et al., 2005
Camellia sinensis Inhibits NF-κB 5–30µM (of EGCG) Human endothelial cells Hong et al., 2007
Reduces VCAM-1 10–100µM (of EGCG) In vitro endothelial cells Ludwig et al., 2004
Decreases TNF-α 379mg Obese, hypertensive humans Bogdanski et al., 2012
Coptis chinensis Decreases NF-κB 150mg/kg Atherosclerotic renovascular rats Wan et al., 2013
25µM (of Berberine) Rat aortic endothelial cells Wang et al., 2009
Inhibits VCAM-1 25µM (of Berberine) Rat aortic endothelial cells Wang et al., 2009
Coriandrum sativum Decreases NF-κB 150µg/ml LPS-stimulated RAW 264.7 Wu et al., 2010
Crataegus spp. Decreases TNF-α 100mg/kg STZ-induced diabetic rats Topal et al., 2013
Decreases IL-6 100mg/kg STZ-induced diabetic rats Topal et al., 2013
Crocus sativus Inhibits NF-κB 0.1–0.5mL/kg/day Ischemia-reperfusion injury (IRI) in rats Bharti et al., 2012
Panax Inhibits NF-κB 2–5µM (one of its
components)
Mouse cardiomyocytes Ma et al., 2014
10µM (one of its components) Mouse macrophages Wang et al., 2014
Decreases TNF-α 10µM (one of its components) Mouse macrophages Wang et al., 2014
Decreases IL-6 10µM (one of its components) Mouse macrophages Wang et al., 2014
Salviae miltiorrhizae Decreases TNF-α 100µg/ml Human umbilical vein endothelial cells Cho et al., 2013
Inhibits NF-κB 100µg/ml Human umbilical vein endothelial cells Cho et al., 2013
Inhibits VCAM-1 100µg/ml Human umbilical vein endothelial cells Cho et al., 2013
blood cells synthesize H2S from polysulfides that were extracted
from garlic. They also reported that garlic (500µg/ml) and
garlic compounds-mediated increase in H2S is correlated with an
increase in vasorelaxant activities in rat aortic rings (Benavides
et al., 2007). Moreover, treatment with 50µM garlic-derived
DADS induce an increase in expression of Connexin-43 (Cx43),
a gap junction protein whose expression is correlated with a
reduced VSMC proliferation and DNA synthesis (Joshi et al.,
2012; Table 4).
Garlic’s ability to inhibit ACE activity has also been recognized
(Sendl et al., 1992), and in this regard gamma-glutamyl-cysteines
have been identified as the antagonists (Sendl et al., 1992). In
addition, a daily dose of 150 and 400mg/kg of aqueous garlic
extracts caused a reduction of VCAM-1 in fructose-fed rats
(Vazquez-Prieto et al., 2011). Constituents of Garlic dampen Ang
II-induced vasoconstrictor responses, antagonize endothelin-1
induced vasoconstriction, inhibit VSMCs proliferation in smooth
muscles isolated from SHR and abrogate the activation of NF-κB
(Banerjee et al., 2002; Castro et al., 2010; Pan et al., 2012). These
effects are modulated by Allicin after the reaction of Alliin with
the enzyme Alliinase (Frishman et al., 2009; Qidwai and Ashfaq,
2013).
Despite having these multifarious therapeutic effects, garlic
also produces a few minor side effects. Several articles report
garlic’s ability to cause abdominal swelling, heartburn, flatulence,
and acid reflux (Yang et al., 2011; Ried et al., 2013). Individuals
under anticoagulant management are advised to avoid garlic
consumption throughout the duration of treatment as the anti-
hemostatic effect may be far more potent and detrimental
(Qidwai and Ashfaq, 2013).
Andrographis paniculata (King of Bitter)
Andrographis paniculata is a plant that is commonly known
as the “King of bitter” (Awang et al., 2012). A. paniculata
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TABLE 4 | Commonly used antihypertensive plants with anti-proliferative activity.
Herb Effect Concentration/Dose Experimental setting/Model References
Allium sativum Induces Cx43 expression 50µM Sprague-Dawley rat thoracic aortic
VSMCs
Joshi et al., 2012
Inhibits Ang-II-induced cell cycle
progression
100µM (two of its components) VSMCs isolated from SHR Castro et al., 2010
Camellia sinensis Increases HO-1 enzyme 0–50µM Human aortic smooth muscle cells Liu et al., 2014
Coptis chinensis Inhibits cardiac hypertrophy 300mg/kg Rat isolated cardiomyocytes
(insulin-induced hypertrophy)
Zhang et al., 2011
Panax Inhibits ERK pathway activation 10% of plasma isolated from rats
injected with 200mg/kg of the extract
PDGF-treated rat VSMCs Zhang et al., 2012
Decreases CDK4, pRb, and
cyclin D1
20–40mg/ml SHR thoracic aortic VSMCs Tao and Lei, 2012
Decreases β-galactosidase 20–40mg/ml SHR and WKY rat thoracic aortic VSMCs Tao and Lei, 2012
Salviae miltiorrhizae Inhibits PDGF proliferation 100µg/ml Sprague-Dawley rat thoracic aortic
VSMCs
Cho et al., 2013
TABLE 5 | Commonly used antihypertensive plants with diuretic activity.
Herb Effect Concentration/Dose Experimental setting/Model References
Hibiscus sabdariffa Lowers uric acid concentration 16 g/day Healthy men Ali et al., 2005
1500–2500mg/kg SHR Alarcon-Alonso et al., 2012
Reduces plasma Na+ levels 250mg Stage 1 and 2 hypertensive humans Herrera-Arellano et al., 2007
Nigella sativa Increases Na+, K+, and Cl− in urine 5ml/kg/day SHR Zaoui et al., 2000
has been part of eastern and southeastern Asian traditional
medicine as a treatment for cold, CVDs (Awang et al.,
2012) and fever (Kunwar et al., 2010). It has been shown
to possess anti-bacterial, anti-inflammatory (Awang et al.,
2012), and antioxidant effects. Several hypotensive labdane-type
diterpenoid compounds have been identified in Andrographis
paniculatia extracts. These include andrographolide, 14-deoxy-
11,12-didehydroandrographolide and 14-deoxyandrographolide
(Awang et al., 2012). However, no clinical trials have yet been
conducted using A. paniculata.
Treatments with extracts of A. paniculata decrease ACE
and ROS activities in spontaneously hypertensive rats (SHR)
leading to a decrease in BP (Zhang and Tan, 1996; Table 1).
Both 14-deoxy-11,12-didehydroandrographolide and 14-
deoxyandrographolide (1mg/ml in 40% ethanol, dose used:
0.1mg for each substance) reduce vascular resistance reflected
by decreased coronary perfusion pressure (an index of vascular
tone) in rat isolated hearts (Langendorff model; Awang et al.,
2012; Table 2). Moreover, crude extracts with high content of
14-deoxy-11,12-didehydroandrographolide induced dramatic
hypotensive effects (Awang et al., 2012). This was apparently
due to increased NO release which consequently induced
vasodilation (Awang et al., 2012). In addition, 14-deoxy-11,12-
didehydroandrographolide inhibited the rise in intracellular
Ca2+ via receptor- and voltage-gated Ca2+ channels (Awang
et al., 2012).
In addition to its antioxidant (Lobo et al., 2010) and anti-
inflammatory (Kunwar et al., 2010) characteristics, this herb can
potently inhibit the activation of NFκB (Das et al., 2012; Table 3).
Other reports also indicate that A. paniculata exhibits anti-
inflammatory activities in natriuretic peptide receptor-A (Npr1)-
gene knockout mice (Das et al., 2012). Indeed, a daily 4mg/kg
dose of andrographolide caused a significant reduction in the
production of NF-κB (Das et al., 2012).
Apium graveolens (Celery)
The hypotensive effect of celery has been reported in in vivo
animal studies. Seed extracts [300mg/kg body weight, aqueous-
ethanolic (20/80, v/v), hexanic and methanolic] of Apium
graveolens reduce blood pressure in deoxycorticosterone acetate-
induced hypertensive rats (Moghadam et al., 2013). Hexanic
extract was by far the more potent in lowering BP in comparison
to other solvent extracts. This was explained by greater retention
of n-butylphthalide, which has been identified as the source
of celery’s flavor and aromatic odor (Moghadam et al., 2013).
Similarly, this phthalide was reported to decrease BP in
another animal model of hypertension (SHRs; Tsi and Tan,
1997).
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TABLE 6 | Commonly used plants that were studied in clinical trials, and details of these trials.
Herb Design Population
size
Condition Dose Duration Effect Magnitude of
change
References
Allium
sativum
Double-blind, parallel,
randomized,
placebo-controlled
50 Uncontrolled
hypertension
960 mg/day aged garlic
extract
12 weeks SBP decrease 10.2 ± 4.3mmHg Ried et al., 2010
Placebo-controlled,
crossover
6 Mild hypertension 2600 mg/day (4 tablets,
650mg each) garlic powder
10 days SBP decrease 17mmHg Mousa and
Mousa, 2007
Double-blind, parallel,
randomized,
placebo-controlled
79 Uncontrolled
hypertension
480 mg/day aged garlic
extract
12 weeks SBP decrease 11.8 ± 5.4 Ried et al., 2013
Randomized, parallel,
placebo-controlled
210 Stage 1
hypertension
300–1500 mg/day garlic
powder
24 weeks SBP and DBP
decrease
9.2 and
6.26mmHg
Ashraf et al., 2013
Camellia
sinensis
Double-blind,
placebo-controlled
20 Mild hypertension 7.6 g tea leaves in 400ml
water
1 h SBP and DBP
increase
1.7 and 0.9mmHg
(green tea)
Hodgson et al.,
1999
0.7mmHg each
(black tea)
Randomized, parallel,
placebo-controlled
56 Obese,
hypertension
379mg green tea extract 12 weeks SBP and DBP
decrease
4 each mmHg Bogdanski et al.,
2012
Randomized, parallel,
placebo-controlled
95 Mild hypertension 4479mg (3 cups/day,
1493mg each) black tea
24 weeks SBP and DBP
decrease
2 and 2.1mmHg Hodgson et al.,
2012
Crataegus
spp.
Randomized,
double-blind,
placebo-controlled
36 Mild hypertension 500 mg/day extract 10 weeks DBP 13.1mmHg Walker et al., 2002
Randomized,
double-blind,
placebo-controlled
92 Mild hypertension 2.7–3 mg/day flavonoids
(contained in
Hydro-alcoholic extract)
4 months SBP and DBP
decrease
13 and 8mmHg Asgary et al., 2004
Crocus
sativus
Randomized,
double-blind,
placebo-controlled
30 Healthy 400 mg/day 7 days SBP and MAP
decrease
11 and 5mmHg Modaghegh et al.,
2008
Hibiscus
sabdariffa
Randomized,
captopril-controlled
75 Mild to moderate
hypertension
10 g/day dried calyx 4 weeks SBP and DBP
decrease
15.32 and
11.29mmHg
Herrera-Arellano
et al., 2004
Randomized,
double-blind,
Lisinopril-controlled
193 Stage 1 and 2
hypertension
250mg dried calyx extract 4 weeks SBP and DBP
decrease
16.59 and
11.8mmHg
Randomized,
double-blind,
placebo-controlled
65 Pre- and mild
hypertension
720mL/day (3 servings,
240mL each) hibiscus tea
(3.75 g hibiscus)
6 weeks SBP, DBP, and
MAP decrease
7.2, 3.1, and
4.5mmHg
McKay et al., 2010
Nigella
sativa
Randomized,
double-blind,
placebo-controlled
108 Mild hypertension 200 and 400 mg/day (100
and 200 twice a day)
aqueous seed extract
8 weeks SBP and DBP
decrease
2.2 and 1.1mmHg Dehkordi and
Kamkhah, 2008
LDL-cholestrol
reduction
Randomized,
double-blind,
placebo-controlled
70 Healthy 5mL/day (2.5 twice a day)
NS oil
8 weeks SBP and DBP
decrease
10.6 and
9.6mmHg
Fallah Huseini
et al., 2013
Panax Randomized,
placebo-controlled
90 Mild hypertension 300 mg/day P. ginseng
extract
8 weeks SBP and DBP
decrease
3.1 and 2.3mmHg Rhee et al., 2014
Randomized,
double-blind,
placebo-controlled
64 Essential
hypertension
3 g/day P. quinquefolius 12 weeks SBP decrease 17.4mmHg Mucalo et al.,
2013
Randomized,
double-blind,
crossover
23 Healthy 400mg 3h SBP and DBP
decrease
4.8 and 3.6mmHg Jovanovski et al.,
2014
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Apigenin, a flavone isolate of A. graveolens, blocked aortic
ring contractions caused by cumulative calcium increases in
high potassium (60mM) Krebs’ solution; this was suggested
to result from blocking of Ca2+ influx via calcium channels
(voltage and receptor gated; Ko et al., 1991). The inhibition of
calcium entry from extracellular sources was also responsible for
apigenin-dependent relaxation of noradrenaline-preconstricted
rat isolated aorta. This action was not influenced by either
methylene blue, endothelial denudation, indomethacin,
nifedipine, or caffeine, and the concentration of intracellular
signaling molecules (cAMP, cGMP, and inositol monophosphate)
were unaltered (Ko et al., 1991). Importantly, extracts and
constituents of celery have been reported to lower arterial
pressure in humans, possibly by lowering levels of circulating
catecholamines and decreasing vascular resistance (Houston,
2005). Interestingly, this herb can reduce oxidative stress by
virtue of its flavonoid content that potentiates antioxidant
mechanisms (Popovic et al., 2006).
Bidens pilosa L. (Beggar’s Tick,
Black-Jack, etc.)
This plant belongs to the family Asteraceae and has several
common names: beggar’s tick, black-jack, and broom stick. In
addition to exhibiting antihypertensive effects, B. pilosa also
possesses anti-cancer, anti-bacterial, anti-malarial, and anti-
obesity properties (Bartolome et al., 2013). As of yet, no clinical
trials have determined the potential effect of this plant on
hypertension. However, extracts of its leaves were able to prevent
and attenuate high blood pressure in different hypertensive rat
models (SHRs and fructose-fed hypertensive rats) as well as
normotensive Wistar rats (Dimo et al., 2002; Bartolome et al.,
2013; Tables 2, 3). In fructose-fed rats, after 6 h of treatment with
75 and 150mg/kg of methanolic leaf extract of B. pilosa, SBP
was reduced by 17 and 21%, respectively (Dimo et al., 2002).
Interestingly, the extract also showed preventive effect on SBP
by 9 and 11% at 75 and 150mg/kg, respectively. Using the same
animal model, it was also shown that a 3-week treatment with
aqueous and methylene chloride extracts of B. pilosa can prevent
fructose-induced hypertension (Dimo et al., 2001).
There are conflicting reports regarding B. piloas’s effect on
insulin sensitivity, with some studies showing improvement
in insulin sensitivity (Dimo et al., 2002; Bartolome et al.,
2013), while others reporting no effect on plasma insulin
concentration (Dimo et al., 2001). However, there is a definite
agreement on its vasorelaxant responses (Dimo et al., 2002;
Bartolome et al., 2013). Cumulative doses of a neutral extract of
B. pilosa (with an optimum concentration of 0.32mg/ml) relaxed
potassium chloride and noradrenaline pre-constricted rat aortas
(Nguelefack et al., 2005). The mechanism of vasodilation has
not been completely deciphered. It appears to be independent
of ATP-sensitive potassium channels, but possibly involves a
calcium channel antagonism and cyclooxygenase metabolite
(Nguelefack et al., 2005). Importantly, the crude extract, its
fractions or the isolated phytochemicals of B. pilosa have been
reported to display radical scavenging ability (Bartolome et al.,
2013). Two of these compounds, luteolin (a flavonoid) and ethyl
caffeate (ester of hydroxycinnamic acid), exhibit potent anti-
inflammatory activities. For example, luteolin blocked the effects
of inflammatory cytokines, TNF-α, and IL-6 (Xagorari et al.,
2001). Moreover, both luteolin (Xagorari et al., 2001) and ethyl
caffeate (Chiang et al., 2005) can inhibit the pro-inflammatory
transcription factor, NF-κB.
Camellia sinensis (Tea)
Collectively, the teas prepared from Camellia sinensis are the
most frequently consumed beverages and are second only to
water, worldwide (Faria et al., 2012). Tea has pleiotropic effects
including antibacterial, anti-inflammatory (Deka andVita, 2011),
anti-cancer, anti-diabetic, as well as antihypertensive actions
(Deka and Vita, 2011; Table 1). The data on the hypotensive
effect of tea are not concrete. Hodgson et al. reported increases
in BP after 30min of consuming tea, with the BP returning to
its baseline value after 60min (Hodgson et al., 1999). Another
study suggested that green tea causes a decrease in SBP for
participants with BP of 140mmHg or higher (Nagao et al.,
2007). A meta-analysis of five trials came to conclusion of no
change in blood pressure subsequent to drinking tea (Taubert
et al., 2007). However, a more recent meta-analysis study of
randomized controlled trials demonstrated that green tea reduces
both SBP and DBP by 1.98 and 1.92, respectively (Peng et al.,
2014). Likewise, other meta-analysis of randomized controlled
trials came to the same conclusion that green tea reduces SBP
and DBP by 1.8 and 1.4mmHg, respectively. Interestingly, it
was reported that green tea evoked a more powerful hypotensive
effect compared to black tea, and that long-term tea consumption
produced a more significant SBP and DBP reduction. Moreover,
in a double-blind, placebo-controlled trial, obese hypertensive
patients who received 379mg green tea extract for 12 weeks
exhibited a significant decrease in SBP and DBP by 4mmHg
each (Bogdanski et al., 2012). Another randomized double-blind,
placebo-controlled trial concluded that hypertensive subjects
who consumed 4479mg (3 cups/day, 1493mg each) of black tea
for 24 weeks exhibited a significant reduction in both SBP and
DBP by 2 and 2.1mmHg, respectively (Hodgson et al., 2012). It is
important to note here that ingestion of green or black tea (7.6 g
in 400ml water) by mild hypertensive subjects did not decrease
blood pressure. On the contrary, green or black tea ingestion
caused a non-significant increase in SBP/DBP by 1.7/0.9 and
0.7/0.7mmHg, respectively (Hodgson et al., 1999).
Catechins, the major flavonoids in tea, include (−)-
epicatechin (EC), (−)-epicatechin-3-gallate (ECG), (−)-
epigallocatechin (EGC), and (−)-epigallocatechin-3-gallate
(EGCG; Deka and Vita, 2011). EGCG constitutes the primary
component of tea’s total catechins (Babu and Liu, 2008;
Faria et al., 2012; Slevin et al., 2012; Thomson et al., 2012).
Constituents of tea lessen the risk of hypertension through
several mechanisms, such as attenuation of oxidative stress
(Table 1). Green tea has been reported to increase CAT
antioxidant enzyme while simultaneously blocking AT1
receptors in streptozotocin-treated rats (Thomson et al., 2012).
It has also been reported to upregulate the expression of
antioxidants genes such as SOD1 and GST in C57BL/6 mice
(Newsome et al., 2014). Another mechanism for oxidative stress
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reduction by tea is the inhibition of eNOS uncoupling (Faria
et al., 2012). In addition, green tea has the capacity to scavenge
superoxides (Nakagawa and Yokozawa, 2002) in vitro as well as
attenuate NAPDH oxidase production (Ribaldo et al., 2009) in
diabetic SHRs.
Flavonoids are noted for their vasorelaxant responses,
including flow-mediated (Ras et al., 2011), and endothelial-
dependent dilation (Oyama et al., 2010; Table 2). Black tea
catechins are converted by an enzymatic (polyphenol oxidase
and peroxidase) oxidative polymerization reaction to tannins:
theaflavins (benztropolone ring) and thearubigins, both of which
are orange-red colored polyphenolic pigments that are also
potent vasodilators (Yang et al., 2011). A couple of clinical
studies have reported black tea’s positive effect on flow-mediated
dilation (FMD), an index of endothelial function (Duffy et al.,
2001; Hodgson et al., 2002). In subjects with moderately elevated
cholesterol and/or triglyceride levels, consumption of black tea
increased FMD in brachial arteries (Hodgson et al., 2002) as well
as in patients with coronary arterial disease (450mL of tea or
water—short-term, after 2 h; and 900mL of tea or water/day for 4
weeks long-term, n = 50 subjects; Duffy et al., 2001). In a clinical
trial, Oyama et al. (2010) used venous occlusion strain-gauge
plethysmography to demonstrate the beneficial effects of green
tea catechins (580mg/day for 4 weeks) on blood flow in forearms
of smokers. The data revealed a significant increase in blood flow
due to an augmented release of NO with a concomitant decrease
in levels of both asymmetrical dimethylarginine (an endogenous
inhibitor of eNOS) and oxidative stress (Oyama et al., 2010;
Table 6).
The bioactive components of tea are reported to express
anti-inflammatory properties (Table 3), reflected by mitigated
expression and release of different cytokines. In a clinical double-
blind, placebo-controlled study on 56 obese, hypertensive males
and females, green tea extract (379 mg/day for 3 months) caused
a decrease in BP as well as TNF-α levels (Bogdanski et al., 2012).
In other studies, EGCG (Ludwig et al., 2004) and theaflavin
(Lü et al., 2005) derived from tea have been reported to reduce
VCAM-1 levels. In addition, EGCG was able to inhibit NF-
κB activation in human endothelial cells (Hong et al., 2007).
Interestingly, EGCG derived from green tea also elicited a
concentration-dependent inhibition of proliferation in human
aortic VSMCs by increasing HO-1 enzyme expression (Liu et al.,
2014).
Coptis chinensis (Goldthread)
Coptis chinensis, commonly known as Chinese goldthread, is
widely used in Chinese folk medicine (Affuso et al., 2010).
Evidence indicates that goldthread, and its main component
Berberine (BBR), have the ability to lower blood pressure (Affuso
et al., 2010; Xiong et al., 2013). Indeed, a recent meta-analysis
of twenty-seven randomized controlled trials involving 2569
patients reported that BBR can cause a significant hypotensive
effect (Lan et al., 2015). In addition, this meta-analysis concluded
that combined with an oral hypotensor, BBR can significantly
reduce BP more than the hypotensor alone can do. The
magnitude of the decrease was determined to be an average of
4.91 and 2mmHg for SBP andDBP, respectively (Lan et al., 2015).
Several mechanisms have been proposed for Chinese
goldthread’s antihypertensive effect. One mechanism appears
to be via amelioration of oxidative stress (Zhang et al., 2011;
Wan et al., 2013; Table 1). Indeed, BBR (150mg/kg) is reported
to scavenge ROS, inhibit NADPH oxidase (Wan et al., 2013),
and increase the antioxidant enzyme, SOD, in rats with
atherosclerotic renovascular disease.
Constituents of goldthread also act by relaxing arterial tissues
through endothelial-dependent and independent routes (Affuso
et al., 2010). In chronic intermittent hypobaric hypoxic and
normoxic animal models, goldthread has been shown to relax
NE-induced contractions in rat isolated thoracic aortic rings
(Zhang et al., 2011). The same authors also reported BBR’s
vasorelaxant activity on KCl-induced contractions using the
same models (Zhang et al., 2011). Apparently, BBR elevates
the expression of eNOS with a concomitant rise in NO release
that leads to enhanced flow-mediated vasodilation (Affuso et al.,
2010; Zhang et al., 2011). This dilation is likely mediated by
the vasodilator PGI2 as well as the opening of KATP channels
and blockage of Ca2+ influx (Zhang et al., 2011). In a clinical
study, BBR (1.2 g/day for 1 month) decreased the formation of
endothelial microparticles (EMPs) which are known to induce
endothelial dysfunction and pro-coagulant activity in healthy
humans (Wang et al., 2009; Affuso et al., 2010).
In addition, BBR isolate of Chinese goldthread inhibits
endothelial injury (Wang et al., 2009) modulates inflammatory
pathways through suppression of transcription factor NF-κB,
VCAM-1 expression, VSMC proliferation (Affuso et al., 2010;
Wan et al., 2013; Table 4). It also improves lipid profile
by reducing total and LDL cholesterol, and cardiac muscle
hypertrophy (Zhang et al., 2011).
Coriandrum sativum (Cilantro or Coriander)
In several countries, coriander (also known as cilantro or dhania)
is not only used as a culinary ingredient (Anilakumar et al.,
2010; Wu et al., 2010) but also as a traditional medicine for the
treatment of cardiovascular and gastrointestinal diseases (Jabeen
et al., 2009).
To the best of our knowledge, no clinical trials have been
conducted to assess coriander’s effects on BP. However, coriander
has been reported to exhibit antioxidant properties (Sreelatha
et al., 2009; Cioanca et al., 2013; Ramkissoon et al., 2013).
In isoproterenol-induced myocardial infarction (MI) model of
cardiotoxicity, coriander extract (200 and 300mg/kg) inactivated
β-adrenoceptor-induced ROS production and also prevented MI
by inhibiting myofibrillar damage (Patel et al., 2012; Table 1).
Coriander leaves’ extracts also increased antioxidants enzymes
(Sreelatha et al., 2009) and its seeds’ powder (5 and 10%) showed
similar effect on the antioxidant GPX (Anilakumar et al., 2010).
Other studies have also reported similar antioxidant activities of
coriander (Cioanca et al., 2013; Ramkissoon et al., 2013).
Vasodilatory effects of coriander are well-established. Indeed,
intravenous application of aqueous methanolic extract of
dried, ground coriander seeds (1–30mg/ml) produced a dose-
dependent fall in SBP, DBP, and mean arterial blood pressure
(MABP) in normotensive Sprague-Dawley rats by 40.84 ±
6.34% (Jabeen et al., 2009). The same report also showed that
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coriander fruit extracts produced dose-dependent relaxation of
pre-constricted (phenylephrine and potassium chloride) rabbit
aortas, and this response was atropine and calcium-channel
dependent (Jabeen et al., 2009). Further, the same extracts showed
diuretic affects as well. The active component of which should
act synergistically with the vasoactive constituent to complement
the treatment and management of hypertension (Jabeen et al.,
2009). Moreover, coriander acts as an inhibitory agent to reduce
the activities of NF-κB and iNOS (Wu et al., 2010).
Crataegus spp. (Hawthorns)
Hawthorns (hawberry or thorn apple) plants are shrubs that
belong to a genus comprising almost 300 species (Tassell et al.,
2010) that have been used in traditional medicine for thousands
of years (Tassell et al., 2010; Asher et al., 2012). Hawthorns have
been used for treatment of CVDs since the seventeenth century
(Asher et al., 2012).
Modest decreases in blood pressure have been observed in a
few human-based studies with a demographic of hypertensive
patients (Walker et al., 2002; Tassell et al., 2010). In a
randomized, double-blind, placebo-controlled study where
mildly hypertensive subjects were treated with 500mg of
hawthorn extract for 10 weeks, a promising tendency for a
reduction in DBP (by 13.1mmHg) was reported (Walker et al.,
2002). It is argued that the dose and duration were not sufficient
for a more effective result to be noted. Indeed, in phytotherapy
practice, a significant decrease in BP is only noted after a
longer duration and higher doses (Bone and Mills, 2013), In
another randomized, double-blind, placebo-controlled clinical
study, administration of hydro-alcoholic extracts of Crataegus
curvisepala Lind flowers to hypertensive patients (age range 40–
60 years) for 3 months induced a decrease in both SBP and DBP
by around 13 and 8mmHg, respectively (Asgary et al., 2004).
The aforemnetioned antihypertensive actions are credited
to the plant’s multiple components: flavonoids (hyperoside,
quercetin, rutin, and vitexin) and oligomeric proanthocyanidins
(OPCs, epicatechin, procyanidin, and procyanidin B-2; Valli and
Giardina, 2002; Houston, 2005; Asher et al., 2012; Yang and Liu,
2012). Quercetin, a major polyphenolic flavonoid in hawthorn
shrubs, expresses numerous bioactive functions including anti-
oxidant, anti-inflammatory, and vasorelaxant effects. Quercetin
supplement intervention studies have demonstrated a reduction
in blood pressure of hypertensive subjects (Larson et al., 2012).
Interestingly, hawthorn extracts have an effect on both VSMCs
and endothelial cells (Tassell et al., 2010). The latter interaction
is attributable to increased NOS activity and hence NO release
(Brixius et al., 2006; Anselm et al., 2009), possibly due to an
enhanced phosphorylation of eNOS at serine 1177 (Brixius et al.,
2006; Anselm et al., 2009; Table 2). In porcine isolated coronary
arterial rings, WS 1442 (an extract of Crataegus leaves with
flowers) induced endothelium-dependent relaxation through the
activation of multiple signaling pathways, including ROS, Src,
PI3-kinase, Akt, and eNOS (Anselm et al., 2009). Moreover,
WS 1442 caused endothelium-dependent and NO-mediated
vasorelaxation of phenylephrine-preconstricted rings of rat aorta
as well as human internal mammaria (Brixius et al., 2006). In
the L-NAME-induced hypertension model, the blood pressure
decreased after the administration of Crataegus tanacetifolia leaf
extract or its isolate, hyperoside. Both C. tanacetifolia extract
and hyperoside display protective effects at multiple levels. These
include improving hyperlipidemia, decreasing body weight,
resolving hyperplasia, reducing thickness of the vascular medial
layer as well as improving kidney function. Such effects appear
to be mediated by an increase in diuretic activity, eﬄux of water
and sodium, as well as expression of NOS enzyme. Together, all
of these mechanistic actions contribute to the amelioration of
hypertensive outcome (Koçyildiz et al., 2006).
As part of the integrated cardiovascular beneficial
bioprocesses, hawthorn has the capacity to scavenge ROS (Tassell
et al., 2010; Cheng et al., 2013; Table 1), up-regulate antioxidant
enzymes (SOD, CAT) and augment the concentration of the
reducing glutathione (GSH; Tassell et al., 2010). Moreover,
hawthorn extracts express anti-inflammatory activity, which
is mirrored by the decline in concentrations of NF-κB, TNF-α
(Topal et al., 2013), VCAM-1 (Shin et al., 2012), iNOS, and IL-6
(Topal et al., 2013).
Crocus sativus (Saffron)
Saffron (common name), a plant indigenous to Southwest Asia
(Iran, Pakistan, and India), Spain, Greece, and Morocco, is a
stemless herb whose medicinal values have been sought for over
4000 years (Srivastava et al., 2010). Saffron’s main components
include crocin, picrocrocin, safranal, and crocetin (Srivastava
et al., 2010; Mehdizadeh et al., 2013) and these molecules exhibit
different mechanisms of action (Mokhtari-Zaer et al., 2015).
Several reports support the use of saffron for anti-hypertensive
benefits. A clinical study reported that 400mg of saffron tablets
administered for 7 days were able to significantly reduce the
SBP and mean arterial pressure in healthy humans by 11
and 5mmHg, respectively (Modaghegh et al., 2008). Saffron
demonstrates vasorelaxant activities in different animal models.
Extracts of C. sativus petals (rich in flavonoids and anthocyanins)
dose-dependently reduced the BP of male Sprague-Dawley rats,
possibly by modulating peripheral vascular resistance (Fatehi
et al., 2003). Moreover, extract of C. sativus stigma (10mg/kg),
and two of its primary components [Crocin (200mg/kg) and
Safranal (1mg/kg)], attenuated MABP in normotensive and
desoxycorticosterone acetate (DOCA)-salt induced hypertensive
male Wistar rats (Imenshahidi et al., 2010). More recently, it
was shown that chronic administration of safranal (1, 2, and
4 mg/Kg/day) reduced SBP in DOCA-salt hypertensive but not
normotensive rats (Imenshahidi et al., 2015).
Saffron relaxes non-vascular muscles as well. Indeed, extracts
of saffron decreased contractility and heart rate of guinea-pig
isolated perfused hearts (Langendorff procedure) by blocking
Ca2+ channels, opening potassium channels, and antagonizing
β-adrenoceptors (Boskabady et al., 2008; Table 2). In addition,
safranal (0.1–0.5mL/kg daily) offers protection in a rat
model of myocardial ischemia-reperfusion injury via enhanced
phosphorylation of protein kinase B (Akt)/glycogen synthase
kinase-3β (GSK-3β)/eNOS pathway, attenuation of IKK-β/NF-
κB activity, normalization of the antioxidant reserve and up-
regulation of the anti-apoptotic route (Bharti et al., 2012;
Table 2).
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Saffron’s antioxidant ability has also been widely reported. It
was shown to reduce oxidative stress (El-Beshbishy et al., 2012;
Mehdizadeh et al., 2013) and increase antioxidant enzymes, such
as SOD (Premkumar et al., 2003; El-Beshbishy et al., 2012),
CAT, GPX, and reduced GSH (Premkumar et al., 2003;Table 1).
20–80mg/kg of saffron’s aqueous extracts were able to increase
antioxidants levels in genotoxin-treated mice (Premkumar et al.,
2003). Crocin treatment (200mg/kg for 7 days) of beryllium
chloride-induced model of oxidative stress in male Wistar
rats resulted in a significant decline in oxidative stress and
the corresponding up-regulation of antioxidant enzymes (El-
Beshbishy et al., 2012). Moreover, saffron and its constituents
also possess an inherent ability to inhibit inflammatory pathways,
including NF-κB (Nam et al., 2010; Bharti et al., 2012) and TNF-α
expression (Nam et al., 2010).
Cymbopogon citratus (Lemongrass)
Lemongrass (common name) has been widely used in traditional
medicine of Brazil, China, and Southern Asia (Devi et al., 2012).
It has been reported to possess antihypertensive properties, which
have been attributed to its active phytochemicals, the principle of
which being Citral (Devi et al., 2011, 2012). However, no clinical
trials have yet investigated the effect of Lemongrass on BP.
The relaxant effect of lemongrass has been demonstrated
in several different tissues, including the rabbit ileum (Devi
et al., 2011), rat aortic rings (Devi et al., 2012), and the rat
mesentery (Bastos et al., 2010; Table 2). For instance, Citral or
crude extracts of C. citratus (leaves, stems, or roots) generated a
dose-dependent vasorelaxation in phenylephrine pre-constricted
aortic rings from male WKRs or SHRs (Devi et al., 2012).
Further, the underlying mechanism for this relaxation appeared
to be mediated by activation of NO and/or the inhibition of
calcium channels (Devi et al., 2012). Likewise, administration of
an intravenous bolus of Citronellol, an acyclic monoterpenoid
isolated from lemongrass, to male Wistar rats produced a
hypotensive response. This hypotensive effect was not affected
by L-NAME, indomethacin, atropine, or hexamethonium (Bastos
et al., 2010). Citronellol also induced relaxation of rat superior
mesenteric artery via an endothelium-independent mechanism.
Moreover, arteries denuded of endothelium were not reliant
on tetraethylammonium-dependent potassium channels. Rather,
citronellol acted by inhibiting Ca2+-influx through voltage
operated calcium channels (VOCCs) as well as regulating
IP3- and caffeine-gated intracellular Ca
2+ stores (Bastos et al.,
2010).
Lemongrass is known to display moderate antioxidant
activity. In male rats treated with H2O2, 100mg/kg of lemongrass
was able to reduce oxidative stress and increase GSH expression
in testes (Rahim et al., 2013). Results from another study showed
an increase in antioxidant enzymes and molecules such as SOD
and GSH in murine lungs after administering 5 and 10µg
of lemongrass’ extracts (Tiwari et al., 2010). Lemongrass was
reported to suppress ROS molecular activity (Tiwari et al., 2010;
Koh et al., 2012). In addition, lemongrass’ Citral contributes to
the anti-inflammatory pathways by inhibiting NF-κB (Lee et al.,
2008; Francisco et al., 2013) and iNOS activity (Lee et al., 2008;
Figueirinha et al., 2010).
Hibiscus sabdariffa (Roselle)
Hibiscus, widely known as roselle, is used for hypertension, fever,
and other diseases in folk medicine. Different parts of this plant
(buds, calyx, flowers, leaves, and petals—fresh or dried) are used
for health purposes and as refreshing beverages, food items (jams,
preserves), or lotions.
Roselle’s blood pressure lowering effects have been extensively
reported in both animal (Odigie et al., 2003; Ali et al., 2005; Ajay
et al., 2007; Mojiminiyi et al., 2007; McKay et al., 2010; Ojeda
et al., 2010; Inuwa et al., 2012; Hopkins et al., 2013) and human
studies (Onyenekwe et al., 1999; Herrera-Arellano et al., 2004,
2007; Mojiminiyi et al., 2007; Mozaffari-Khosravi et al., 2009;
Inuwa et al., 2012; Hopkins et al., 2013). In a randomized, double-
blind, Lisinopril-controlled clinical trial, antihypertensive effects
were notable subsequent to treatment with dried extract of calyx
(250 mg) for 4 weeks in patients with stage 1 or 2 hypertension
(Herrera-Arellano et al., 2007; Table 6). Indeed, a drop of BP
from 146.48/97.77–129.89/85.96mmHg was noticed (Herrera-
Arellano et al., 2007). In yet another randomized controlled
trial, hypertensive patients ingested 10 g/day of Roselle’s calyx.
After 4 weeks, a significant decrease in SBP and DBP by 15.32
and 11.29mmHg, respectively was reported (Herrera-Arellano
et al., 2004). Additional support for hibiscus’ therapeutic role in
ameliorating hypertension is provided by a report which shows
that in mild and pre-hypertensive patients (65 subjects—30–70
years old), consuming roselle’s tea (240ml—three times a day for
6 weeks) significantly reduces SBP, DBP, andMAP by 7.2, 3.1, and
4.5mmHg, respectively (McKay et al., 2010).
Different mechanisms for roselle’s antihypertensive effect have
been reported. Roselle primes the vasorelaxant pathways of both
endothelial cells (Ajay et al., 2007; Herrera-Arellano et al., 2007)
and VSMCs (Ali et al., 2005; Ajay et al., 2007). Its relaxant
effect is mediated through an increased production of NO (Ajay
et al., 2007; Alarcon-Alonso et al., 2012), inhibition of Ca2+
channels (Ajay et al., 2007) and opening of KATP channels (Sarr
et al., 2009). Additionally, it has been shown to inhibit cardiac
hypertrophy (Odigie et al., 2003; Inuwa et al., 2012), and decrease
heart rates in rats (Odigie et al., 2003).
A strong body of evidence is reported to support roselle’s
ability as a diuretic agent (Onyenekwe et al., 1999; Ali et al., 2005;
Herrera-Arellano et al., 2007; Alarcon-Alonso et al., 2012). One
clinical study detected a lower concentration of uric acid in urine
of healthy humans consuming roselle (Ali et al., 2005). Another
clinical study reflected the decrease in blood sodium content of
stage 1 and 2 hypertensive humans after 4 weeks administration
of 250mg of roselle’s extracts (Herrera-Arellano et al., 2007), thus
verifying its multiple diuretic properties. This diuretic activity is
related to the vasorelaxant effect, as NO elevation is positively
correlated with increases in renal filtration rates (Alarcon-Alonso
et al., 2012).
Roselle exhibits potent antioxidant function (Ali et al., 2005;
McKay et al., 2010). Its anthocyanin extracts (2mg/ml) were
reported to reduce oxidative stress, potentially by scavenging
free radicals in livers of CCl4-treated rats (Ajiboye et al., 2011).
In a clinical study, roselle’s aqueous extracts enhanced the
concentration of cellular antioxidants in healthy humans (Frank
et al., 2012; Table 1). Moreover, it blocks the oxidation of LDL,
Frontiers in Pharmacology | www.frontiersin.org 15 January 2016 | Volume 6 | Article 323
Al Disi et al. Herbs and Hypertension
indicating its role as an anti-atherogenic (Lin et al., 2011). Roselle
also shows anti-inflammatory capacity by inhibiting not only
ACE activity (Herrera-Arellano et al., 2007; Ojeda et al., 2010)
but also the proliferation of VSMCs (Lin et al., 2011). The effect of
roselle on ACE activity was confirmed in a Lisinopril-controlled
clinical trial, where 250mg of its extract was administered to
patients with stage 1 or 2 hypertension (Herrera-Arellano et al.,
2007).
Nigella sativa (Black Cumin; Seed of
Blessing)
Black cumin, also known as Habbatul barakah (seed of blessing),
has been used in the kitchens of Europe, the Middle East,
Africa, and South and Southwest Asia for centuries (Ahmad
et al., 2013; Leong et al., 2013; Tables 2, 5). In addition to
its antihypertensive role, black cumin is also effective against
diabetes and gastrointestinal diseases (Leong et al., 2013).
Thymoquinone (TQ), one of the most abundant and bioactive
components in Nigella sativa’s seeds, has been identified as the
major element in its healing effects (Ahmad et al., 2013).
N. sativa, and its constituents, have been reported to lower
blood pressure in humans and in different animal models
of hypertension (Zaoui et al., 2000; Khattab and Nagi, 2007;
Dehkordi and Kamkhah, 2008; Fallah Huseini et al., 2013)
and also decrease heart rate (Leong et al., 2013). For example,
L-NAME-induced hypertension in rats was ameliorated by
concomitant treatment with thymoquinone (0.5 and 1mg/kg/day
for 4 weeks; Khattab and Nagi, 2007). Improvement in renal
function and antioxidant activity were also noted, evident by
the reduced serum creatinine or increased glutathione in control
vs. L-NAME treated rats, respectively (Khattab and Nagi, 2007).
Likewise, in SHRs, an oral dose of dichloromethane extract of
black cumin seeds (0.6ml/kg/day for 15 days) reduced mean
arterial pressure by 22% and increased diuretic activity (Khattab
andNagi, 2007), mirrored by urinary excretion of urea, Cl−, Na+,
and K+ (Zaoui et al., 2000; Table 5).
A randomized, double-blind placebo-controlled clinical trial
of the effects of N. sativa’s seed extract administrated orally
(either 100 or 200mg, two times per 24 h for 8 weeks) to
mild hypertensive male patients recorded a dose-dependent fall
in both SBP and DBP, in the two treated groups compared
to placebo (Dehkordi and Kamkhah, 2008; Table 6). For the
200mg dose, there was a decrease of around 2.2 and 2mmHg in
SBP and DBP, respectively. Moreover, the NS’s extract reduced
total cholesterol as well as low density lipoprotein (LDL)-
cholesterol relative to pretreatment concentrations (Dehkordi
and Kamkhah, 2008). Again, in a randomized, placebo-
controlled, double-blind study with 70 healthy subjects, N. sativa
oil caused a significant decrease of 10.6 and 9.6mmHg,
respectively in both SBP and DBP (Fallah Huseini et al., 2013).
Another route by which black cumin attenuates hypertension
is by vasorelaxant means. This is illustrated by its ability to
inhibit Ca2+ channels (voltage-gated and ligand-gated) leading
to concomitant relaxation of rat aorta (Leong et al., 2013).
Moreover, TQ is reported to inhibit the release of vasoconstrictor
metabolites of COX-1 (Ahmad et al., 2013) and COX-2 (Ahmad
et al., 2013; Kundu et al., 2013).
TQ’s antihypertensive effects are partly due to its antioxidant
activities as it lowers oxidative stress (Khattab and Nagi, 2007;
Ahmad et al., 2013). Another mechanism that may explain the
hypotensive effect of black cumin pertains to its diuretic action
(Zaoui et al., 2000; Ahmad et al., 2013; Leong et al., 2013).
This has been highlighted by the ability of black cumin seeds to
increase urea, calcium, sodium, and potassium in urine of rats
(Zaoui et al., 2000; Leong et al., 2013), where it also increases
renal filtration and urinary output (Leong et al., 2013). Yet
another mechanism that underlies black cumin’s actions is its
anti-inflammatory property since it inhibits the generation of
TNF-α and NF-κB (Kundu et al., 2013).
Panax (Ginseng)
For centuries, the species Panax, especially the Asian variety, has
been used in folk medicine (Jang et al., 2011; Kim, 2012). Ginseng
is prepared and administered in various forms, either as a solid:
tablets, capsules, dried roots; or as a liquid: oil, extracts or tea
(Valli and Giardina, 2002). P. ginseng (Asian or Korean ginseng),
P. quinquefolius (American ginseng), P. japonicas (Japanese
ginseng) and P. notoginseng (Chinese ginseng) are the four most
common species of ginseng (Valli and Giardina, 2002; Kim,
2012). Interestingly, these—as a group—have the most reported
hypotensive effects. Heterogeneous triterpenoid saponins and
steroid glycosides or ginsenosides (or panaxosides) are the active
principle components of ginseng (Valli and Giardina, 2002; Kim,
2012). In addition to anti-hypertensive effects, ginseng also plays
anti-carcinogenic and antidiabetic roles (Choi et al., 2013).
Although ginseng’s blood pressure lowering effect is widely
reported (Jeon et al., 2000; Valli and Giardina, 2002; Jang et al.,
2011; Kim, 2012; Mucalo et al., 2013; Tables 1, 2), conflicting
reports of elevated blood pressure also exist (Valli and Giardina,
2002; Jang et al., 2011; Kim, 2012). Contextually, low doses of
ginseng raise BP, while higher concentrations are hypotensive
(Jang et al., 2011). A probable explanation for this phenomenon
is the varied action of different ginsenosides (Valli and Giardina,
2002). Interestingly, Kim (2012) has used the term “normalize”
to describe hypotensive and hypertensive actions of ginseng.
Therefore, these studies suggest that ginseng rheostatically adjusts
the BP level in hypotensive patients (Kim, 2012), possibly by
tuning vascular function, modulating the autonomic nervous
system, or regulating the arterial baroreflex.
Several clinical trials have been conducted to assess the
efficacy of ginseng in modulating BP (Table 6). In one
trial, P. ginseng extract rich in ginsenoside protopanaxatriol
(300mg/day) was administered to mild hypertensive patients
and caused a significant decrease of 3.1 and 2.3mmHg in
SBP and DBP, respectively (Rhee et al., 2014). Furthermore,
a randomized, double-blind, placebo-controlled trial where
hypertensive patients ingested American ginseng (3 g/day) for
12 weeks showed that SBP was significantly lowered by 11.7%
(17.4mmHg; Mucalo et al., 2013). Along the same line, another
randomized, double-blind, crossover trial reported that central
SBP and DBP of healthy subjects was significantly reduced
by 4.8 ± 6.8 and 3.6 ± 6.4mmHg, respectively, after hours
of ingesting Ginsenoside Rg3-enriched P. ginseng (400mg;
Jovanovski et al., 2014).
Frontiers in Pharmacology | www.frontiersin.org 16 January 2016 | Volume 6 | Article 323
Al Disi et al. Herbs and Hypertension
The primary mechanism associated with ginseng-induced
hypotensive effect is attributed to an improvement in arterial
function. Indeed, ginseng causes a dramatic increase in eNOS
expression and NO production (Valli and Giardina, 2002; Jang
et al., 2011, 2012; Hong et al., 2012; Pan et al., 2012; Table 2).
Ginsenoside Rg3 (red ginseng) is known to activate eNOS (Valli
and Giardina, 2002; Jang et al., 2011), increase NO and cGMP
levels, as well as activate Ca2+-gated potassium channels (Kim
et al., 1999b). Ginsenosides mediate vasorelaxation of different
vessels in different animals: rat aortas (Kim et al., 1999a), murine
coronary arteries (Pan et al., 2012), and monkey cerebral arteries
(Toda et al., 2001). In the same context, this relaxation may
be aided by ginseng’s ability to diminish secretion of adrenal
catecholamines in hypertensive rats (Jang et al., 2011).
Ginseng also elicits an anti-proliferative effect on VSMCs,
and hence, it can be expected to possess antihypertensive
and anti-atherosclerotic capacities (Table 4). Importantly, results
of a clinical trial indicate that administering 3 g/day of
P. quinquefolius for 12 weeks improves arterial stiffness in
hypertensive patients (Mucalo et al., 2013; Table 6). Further
support for this beneficial effect of ginseng comes from
another clinical trial, where taking 400mg of P. ginseng caused
a significant reduction in aortic Alx, a marker of arterial
stiffness (Jovanovski et al., 2014; Table 6). It has been reported
that Chinese ginseng blocks the activation of extracellular
signal-regulated protein kinases (ERK) pathway, and therefore
inhibits PDGF-induced VSMCs proliferation (Zhang et al.,
2012). Moreover, Chinese and other ginsengs reduced vascular
aging of SHRs compared to WKY rats; this was reflected
by inhibition of proliferation of VSMCs isolated from both
WKY and SHRs. The mechanistic pathway for the effect of
ginseng on SHR VSMCs entailed the decrease in the number
of senescence-associated β-galactosidase (SA-β-gal) positive cells.
In the SHR, expression of p16, and retinoblastoma protein (Rb)
was elevated whereas that of cyclin D1 and cyclin-dependent
kinase 4 (CDK4) was decreased (Tao and Lei, 2012). Further,
red ginseng also attenuated Ang II-induced VSMC growth (Kim,
2012).
Amongst ginseng’s other hypotensive mechanisms is its
antioxidant ability (Table 1). In this regard, it has been reported
that ginsenoside Rg1 (60–120µM) inhibits oxidative stress (Doh
et al., 2013), possibly by increasing antioxidant enzymes (Zhu
et al., 2009) and scavenging free radicals (Zhu et al., 2009).
In addition to its antioxidant effect, ginseng exhibits anti-
inflammatory properties. Indeed, Asian ginseng (red) inhibits the
release of TNF-α (Kim, 2012) as well as attenuates NF-κB and p38
mitogen activated protein kinase (MAPK) pathways (Bak et al.,
2012). It has been suggested that the consequence of this effect is
a reduction in the vasoconstrictor activity of COX-2 enzyme (Bak
et al., 2012; Table 3).
Salviae miltiorrhizae (Chinese Sage)
Salviae miltiorrhizae, known as danshen or red/Chinese sage,
is one of the oldest and most frequently consumed Chinese
traditional herbs (Cho et al., 2013; Jiang et al., 2013a) and is
commonly used for the treatment of CVDs (Ng et al., 2011;
Cho et al., 2013; Jiang et al., 2013a). Danshen’s most effective
components include: salvianolic acid A (SalA), salvianolic acid
B (SalB), danshensu, and tanshinones (Ng et al., 2011; Jiang et al.,
2013a).
Danshen relaxes the vasculature via endothelium-dependent
and endothelium-independent mechanisms. A combination
treatment of danshen and gegen (Pueraria lobata) was shown
to lower blood pressure in SHRs (Ng et al., 2011) and to induce
relaxation of porcine coronary arteries (Hu et al., 2012), rat aorta
(Ng et al., 2011), and basilar arteries (Lam et al., 2010; Table 2).
Similarly, dihydrotanshinone (lipophilic constituent of danshen)
is a vasorelaxant of rat coronary arteries (Lam et al., 2008).
Danshen’s endothelium-dependent relaxations occur via an NO-
dependent mechanism (Chan et al., 2011; Ng et al., 2011; Shou
et al., 2012). SalB-derived vasodilation in rabbit aorta is mediated
by the NO-sGC-cGMP pathway (Shou et al., 2012). Other studies
have also demonstrated that L-NAME inhibits eNOS and blocks
the activity of danshen (Chan et al., 2011; Shou et al., 2012),
further verifying the NO-dependent mechanism of vasodilation.
In VSMCs, danshen exhibits its vasodilating effect by opening of
KATP, Kir, and Kv channels (Ng et al., 2011; Jiang et al., 2013a)
as well as blocking the Ca2+ influx (Lam et al., 2008; Hu et al.,
2012).
Apart from its vasodilatory capacity, danshen expresses
additional anti-hypertensive parameters such as antioxidative,
anti-proliferative, and anti-inflammatory activities. Its extracts
have been shown to decrease ROS production in rat thoracic
aorta (Cho et al., 2013). In a randomized, placebo-controlled
clinical study involving chronic heart disease patients, danshen’s
hydrophilic extract (5 g/twice a day/60 days) increased
antioxidative enzymes like CAT, SOD, and the tripeptide
glutathione (Qian et al., 2012; Table 1). Danshen was also
reported to inhibit PDGF-induced proliferation of VSMCs (Cho
et al., 2013; Table 4). The anti-inflammatory capacity of danshen
was demonstrated by virtue of its ability to inhibit TNF-α,
NF-κB production, and VCAM-1 expression (Cho et al., 2013)
in HUVECs (Table 3). Taken together, these results illustrate the
underlying molecular mechanism for danshen’s antihypertensive
effect.
Zingiber officinale (Ginger)
Ginger, a very common culinary ingredient, is reported to
possess hypotensive properties. In a clinical study, oral (70–
140mg/kg) or intravenous (1.75–3.5mg/kg) administration of
two bioactive constituents of ginger, namely (6)-gingerol and
(6)-shogoal, produced triphasic blood pressure profiles: initial
rapid fall, intermediate rise, and finally a delayed decrease in BP
(Suekawa et al., 1984). Indeed, [6]-gingerol is now considered a
novel angiotensin II type 1 receptor antagonist with an IC50 of
8.17× 10−6M (Liu et al., 2013).
The aqueous extract of ginger (0.05mg/ml) has also been
reported to inhibit lipid peroxidation as well as ACE in rat hearts
(Akinyemi et al., 2013). In addition, zingerone, another active
compound in ginger, can potently scavenge oxidant molecules
like peroxynitrite (Shin et al., 2005). Recently, it was found that
ginger not only reduces levels of total cholesterol, triglyceride,
LDL, and vLDL, but it can also inhibit ACE-1 activity (Akinyemi
et al., 2014).
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CONCLUSION
With CVD remaining as a leading cause of worldwide mortality,
the search for more effective treatments ought to be of prime
importance. An approach that appears promising is CAM
(Frishman et al., 2009; Su and Li, 2011; Orekhov et al., 2013).
Not surprisingly, of all small-molecule new chemical entities
introduced as drugs during the last three decades, a significant
fraction were either obtained from or inspired by nature
(Newman and Cragg, 2012). Perhaps this could explain, at least
partly, the “phenomenon” that more American patients visit
CAM providers than primary care physicians (Eisenberg et al.,
1998; Tachjian et al., 2010). Of relevant interest, it is important
to note that herbal consumption appear to be the most common
type of CAM among CVD patients (Yeh et al., 2006).
In this first part of our review, we discussed the mechanisms
of action of several plants that are most commonly used in the
treatment or management of hypertension.
The evidence presented is strongly indicative of the notion
that herbs and plants are becoming part of evidence-based
medicine in the prevention and/or treatment of CVD. The
pharmacological actions of herbs or herbal isolates appear
to favorably modulate several parameters implicated in the
pathogenesis of blood pressure, including but not limited to
ROS production, VSMC phenotype, endothelial function, platelet
activation, pro-inflammatory signaling, and gene expression.
With such a broad spectrum of actions, one may predict
that herbal remedies will receive even more attention in
the coming years, perhaps accentuating the need for further
experimentations and clinical trials. Indeed, the lack of sufficient
clinical trials constitutes a significant limitation on their use
at the present time. Of equal importance, it may be advisable
that patients be appropriately educated, particularly in relation
to herbs whose consumption has been considered safe for
thousands of years (black cumin, Chinese sage, coriander, garlic,
ginger, ginseng, and tea), and has been supported by sound
scientific evidence such as one based on clinical trials with
large population groups. It is important to note that there
are herbs and plants that could actually raise blood pressure
and thus should be avoided by hypertensive patients. There
are also other limitations for herbal therapy of hypertension.
These limitations would be discussed in the second part of this
review.
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